These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25541517)

  • 41. Interactions between drugs and polymers influencing hot melt extrusion.
    Li Y; Pang H; Guo Z; Lin L; Dong Y; Li G; Lu M; Wu C
    J Pharm Pharmacol; 2014 Feb; 66(2):148-66. PubMed ID: 24325738
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of a HPMC-based controlled release formulation with hot melt extrusion (HME).
    Ma D; Djemai A; Gendron CM; Xi H; Smith M; Kogan J; Li L
    Drug Dev Ind Pharm; 2013 Jul; 39(7):1070-83. PubMed ID: 22803806
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of process parameters and equipment on dry foam formulation properties using indomethacin as model drug.
    Sprunk A; Page S; Kleinebudde P
    Int J Pharm; 2013 Oct; 455(1-2):189-96. PubMed ID: 23891743
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of volumetric scale-up law for processing of a sustained release formulation on co-rotating hot-melt extruders.
    Van Renterghem J; Van de Steene S; Digkas T; Richter M; Vervaet C; De Beer T
    Int J Pharm; 2019 Oct; 569():118587. PubMed ID: 31377409
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hot-melt co-extrusion: requirements, challenges and opportunities for pharmaceutical applications.
    Vynckier AK; Dierickx L; Voorspoels J; Gonnissen Y; Remon JP; Vervaet C
    J Pharm Pharmacol; 2014 Feb; 66(2):167-79. PubMed ID: 24433421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Miniaturization in pharmaceutical extrusion technology: feeding as a challenge of downscaling.
    Muehlenfeld C; Thommes M
    AAPS PharmSciTech; 2012 Mar; 13(1):94-100. PubMed ID: 22160884
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systematical approach of formulation and process development using roller compaction.
    Teng Y; Qiu Z; Wen H
    Eur J Pharm Biopharm; 2009 Oct; 73(2):219-29. PubMed ID: 19406236
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Batch Statistical Process Monitoring Approach to a Cocrystallization Process.
    Sarraguça MC; Ribeiro PRS; Dos Santos AO; Lopes JA
    J Pharm Sci; 2015 Dec; 104(12):4099-4108. PubMed ID: 26308877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Investigation into mixing capability and solid dispersion preparation using the DSM Xplore Pharma Micro Extruder.
    Sakai T; Thommes M
    J Pharm Pharmacol; 2014 Feb; 66(2):218-31. PubMed ID: 24433424
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improvement of the dissolution rate of poorly soluble drugs by solid crystal suspensions.
    Thommes M; Ely DR; Carvajal MT; Pinal R
    Mol Pharm; 2011 Jun; 8(3):727-35. PubMed ID: 21344937
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The applicability of sucrose laurate in hot-melt technology].
    Lang P; Szuts A; Ambrus R; Szabóné RP
    Acta Pharm Hung; 2011; 81(1):43-6. PubMed ID: 21595305
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhancing bioavailability through thermal processing.
    Keen JM; McGinity JW; Williams RO
    Int J Pharm; 2013 Jun; 450(1-2):185-96. PubMed ID: 23618970
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Encapsulation of Liquids Via Extrusion--A Review.
    Tackenberg MW; Kleinebudde P
    Curr Pharm Des; 2015; 21(40):5815-28. PubMed ID: 26446466
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improved group contribution parameter set for the application of solubility parameters to melt extrusion.
    Just S; Sievert F; Thommes M; Breitkreutz J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1191-9. PubMed ID: 23628829
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Application of the quality by design approach to the drug substance manufacturing process of an Fc fusion protein: towards a global multi-step design space.
    Eon-duval A; Valax P; Solacroup T; Broly H; Gleixner R; Strat CL; Sutter J
    J Pharm Sci; 2012 Oct; 101(10):3604-18. PubMed ID: 22821774
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A new method for the continuous production of single dosed controlled release matrix systems based on hot-melt extruded starch: analysis of relevant process parameters and implementation of an in-process control.
    Kipping T; Rein H
    Eur J Pharm Biopharm; 2013 May; 84(1):156-71. PubMed ID: 23313175
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Solubility enhancement with extrusion technology].
    Patyi G; Marosi G; Antal I; Bódis A
    Acta Pharm Hung; 2009; 79(3):124-33. PubMed ID: 20169868
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dissolution enhancement of poorly water-soluble APIs processed by hot-melt extrusion using hydrophilic polymers.
    Maniruzzaman M; Rana MM; Boateng JS; Mitchell JC; Douroumis D
    Drug Dev Ind Pharm; 2013 Feb; 39(2):218-27. PubMed ID: 22452601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of two twin-screw extruders for continuous granulation.
    Djuric D; Van Melkebeke B; Kleinebudde P; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2009 Jan; 71(1):155-60. PubMed ID: 18678245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.